1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Schibli, D.J.
Hwang, P.M.
Vogel, H.J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
38
16749
16755
10.1021/bi990701c
10606506
Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold.
1999
NE
FEBS Lett.
FEBLAL
0165
0014-5793
390
95
98
10.1016/0014-5793(96)00637-0
Antimicrobial Activity of a 13 Amino Acid Tryptophan-Rich Peptide Derived From a Putative Porcine Precursor Protein of a Novel Family of Antibacterial Peptides
1996
10.2210/pdb1d6x/pdb
pdb_00001d6x
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1906.286
ANTIMICROBIAL PEPTIDE, TRITRPTICIN
SYNTHETIC CATHELICIDIN FRAGMENT
1
syn
polymer
no
no
VRRFPWWWPFLRR
VRRFPWWWPFLRR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2000-01-03
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
RCSB
Y
RCSB
1999-10-15
REL
REL
SYNTHETIC PEPTIDE, SEQUENCE FROM A FRAGMENT OF A PORCINE NEUTROPHIL CATHELICIDIN
sample
THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES
structures with favorable non-bond energy
97
19
2D NOESY
DQF-COSY
TOCSY
2D NOESY
TOCSY
400 mM SDS
4.5
AMBIENT
313
K
THE STRUCTURES ARE BASED ON 163 INTERPROTON RESTRAINTS. OF THESE 47 WERE INTRARESIDUE, 50 SEQUENTIAL, AND 66 SHORT-RANGE
RESTRAINED SIMULATED ANNEALING MOLECULAR DYNAMICS
19
minimized average structure
3 MM TRITRPTICIN, 400 MM PERDEUTERATED SDS
3 MM TRITRPTICIN, 400 MM PERDEUTERATED SDS
DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER, BAX
processing
NMRPipe
5.0
BRUNGER, ADAMS, CLORE, DELANO, GROS, GROSSE-KUNSTLEVE, JIANG, KUSZEWSKI, NILGES, PANNU, READ, RICE, SIMONSON, WARREN
refinement
CNS
0.9
500
Bruker
AMX
VAL
1
n
1
VAL
1
A
ARG
2
n
2
ARG
2
A
ARG
3
n
3
ARG
3
A
PHE
4
n
4
PHE
4
A
PRO
5
n
5
PRO
5
A
TRP
6
n
6
TRP
6
A
TRP
7
n
7
TRP
7
A
TRP
8
n
8
TRP
8
A
PRO
9
n
9
PRO
9
A
PHE
10
n
10
PHE
10
A
LEU
11
n
11
LEU
11
A
ARG
12
n
12
ARG
12
A
ARG
13
n
13
ARG
13
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
2
A
A
O
H
PRO
TRP
5
8
1.44
2
A
A
O
H
TRP
LEU
8
11
1.55
5
A
A
O
H
TRP
LEU
8
11
1.56
6
A
A
O
H
TRP
LEU
8
11
1.59
10
A
A
O
H
TRP
LEU
8
11
1.54
15
A
A
O
H
TRP
LEU
8
11
1.54
18
A
A
O
H
TRP
LEU
8
11
1.54
1
A
ARG
3
-175.07
-38.18
1
A
PHE
4
-34.73
96.81
1
A
PRO
5
-66.58
-148.31
1
A
PRO
9
-34.83
-33.50
1
A
ARG
12
-175.16
-69.61
2
A
PHE
4
-34.50
92.66
2
A
TRP
6
-34.85
-29.24
2
A
PRO
9
-39.91
-38.49
2
A
LEU
11
-52.52
-179.32
3
A
PHE
4
-35.53
96.89
3
A
PRO
5
-67.51
-149.44
3
A
PRO
9
-35.00
-31.93
4
A
PHE
4
-34.83
95.87
4
A
PRO
5
-68.69
-147.83
4
A
PRO
9
-36.59
-31.73
5
A
ARG
3
-175.15
-46.09
5
A
PRO
5
-70.54
-143.18
5
A
PRO
9
-34.13
-33.37
5
A
ARG
12
-140.97
-67.49
6
A
PHE
4
-34.93
95.14
6
A
PRO
5
-69.80
-147.33
6
A
LEU
11
-52.75
-178.68
7
A
ARG
3
-96.35
39.07
7
A
PHE
4
-35.03
95.62
7
A
PRO
5
-67.88
-150.83
7
A
PRO
9
-34.85
-32.28
7
A
ARG
12
-161.16
35.06
8
A
PHE
4
-34.90
95.90
8
A
PRO
5
-68.72
-149.19
8
A
PRO
9
-33.86
-32.64
8
A
ARG
12
-129.54
-61.54
9
A
PHE
4
-35.71
96.33
9
A
PRO
5
-68.92
-147.71
9
A
PRO
9
-34.05
-31.07
10
A
ARG
3
-108.41
59.65
10
A
PHE
4
-34.76
95.14
10
A
PRO
5
-69.58
-147.77
10
A
LEU
11
-48.45
-78.64
10
A
ARG
12
-59.22
-76.66
11
A
ARG
3
-96.98
42.46
11
A
PHE
4
-34.94
95.82
11
A
PRO
5
-67.50
-150.06
11
A
PRO
9
-34.79
-32.22
12
A
PHE
4
-34.73
95.22
12
A
PRO
5
-69.06
-149.83
12
A
PRO
9
-34.73
-32.47
12
A
ARG
12
-175.05
124.16
13
A
ARG
2
-60.00
-176.30
13
A
ARG
3
-153.20
30.51
13
A
PHE
4
-34.93
95.73
13
A
PRO
5
-69.15
-148.20
13
A
PRO
9
-34.80
-33.13
13
A
ARG
12
-175.14
145.29
14
A
PHE
4
-34.81
95.65
14
A
PRO
5
-68.05
-149.50
14
A
PRO
9
-35.00
-33.88
14
A
ARG
12
-152.90
-47.00
15
A
ARG
3
-68.98
70.41
15
A
PHE
4
-34.87
95.62
15
A
PRO
5
-69.62
-146.22
15
A
PRO
9
-34.41
-32.38
16
A
ARG
2
-59.06
170.19
16
A
PHE
4
-34.88
96.19
16
A
PRO
5
-69.70
-147.51
16
A
PRO
9
-34.54
-33.61
17
A
ARG
3
-175.06
-37.02
17
A
PHE
4
-34.91
96.61
17
A
PRO
5
-66.76
-149.91
17
A
PRO
9
-35.84
-31.59
17
A
LEU
11
-87.94
38.31
18
A
PHE
4
-35.44
96.15
18
A
PRO
5
-69.31
-147.28
18
A
PRO
9
-34.54
-32.21
19
A
ARG
2
-59.69
-168.82
19
A
ARG
3
-154.52
29.84
19
A
PHE
4
-38.65
98.70
19
A
PRO
5
-63.64
-87.34
19
A
TRP
6
-175.33
-35.55
19
A
PRO
9
-35.05
-33.63
minimized average
THE STRUCTURE OF THE ANTIMICROBIAL PEPTIDE TRITRPTICIN BOUND TO MICELLES-A DISTINCT MEMBRANE-BOUND PEPTIDE FOLD
1
N
N
A
TRP
7
A
TRP
7
HELX_P
A
LEU
11
A
LEU
11
5
1
5
IMMUNE SYSTEM
TYPE IV TURN-TYPE III TURN, IMMUNE SYSTEM
1D6X
PDB
1
1D6X
1
13
1D6X
1
13
1D6X
A
1
1
13
1
P 1